ArticleCardio-oncology (London, England)2024

Cardiovascular and venous thromboembolism risks in cancer patients treated with immune checkpoint inhibitors compared to non-users- a multi-center retrospective study.

Jian-Rong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.